Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
PowerUp Acquisition A | PWUP | Aug 30, 2024 | 11.23 | 0.00 |
PowerUp Acquisition Unit | PWUPU | Aug 30, 2024 | 11.11 | 0.00 |
PPG Industries | PPG | Aug 30, 2024 | 129.73 | +0.69 |
PPL | PPL | Aug 30, 2024 | 31.91 | +0.50 |
PRA Group | PRAA | Aug 30, 2024 | 23.32 | +0.21 |
Prairie Operating | PROP | Aug 30, 2024 | 8.72 | +5.19 |
Praxis Precision Medicines | PRAX | Aug 30, 2024 | 53.15 | +0.21 |
Precigen | PGEN | Aug 30, 2024 | 1.10 | -0.90 |
Precipio | PRPO | Aug 30, 2024 | 6.56 | +1.43 |
Precision BioSciences | DTIL | Aug 30, 2024 | 10.88 | +3.13 |
Precision Drilling | PDS | Aug 30, 2024 | 72.31 | -1.44 |
Precision Optics | POCI | Aug 30, 2024 | 5.25 | +2.74 |
Predictive Oncology | POAI | Aug 30, 2024 | 0.96 | +3.16 |
Preferred Bank | PFBC | Aug 30, 2024 | 82.85 | +1.05 |
Preferred Portfolio Powershares | PGX | Aug 30, 2024 | 11.99 | -0.50 |
Preformed Line Products | PLPC | Aug 30, 2024 | 119.93 | +0.19 |
Prelude Therapeutics | PRLD | Aug 30, 2024 | 5.20 | 0.00 |
Premier A | PINC | Aug 30, 2024 | 20.37 | +0.84 |
Premier Financial | PFC | Aug 30, 2024 | 25.06 | +0.52 |
Prenetics Global A | PRE | Aug 30, 2024 | 4.40 | -9.65 |
Presidio Property Trust A | SQFT | Aug 30, 2024 | 0.66 | -0.74 |
Presidio Property Trust D Pref | SQFTP | Aug 30, 2024 | 15.28 | -1.86 |
Prestige Consumer Healthcare | PBH | Aug 30, 2024 | 74.64 | +0.86 |
Prestige Wealth | PWM | Aug 30, 2024 | 1.06 | -11.67 |
PriceSmart | PSMT | Aug 30, 2024 | 89.58 | +0.65 |
Prime Medicine | PRME | Aug 30, 2024 | 4.28 | -0.70 |
Primech Holdings | PMEC | Aug 30, 2024 | 0.63 | +1.09 |
PrimeEnergy Resources | PNRG | Aug 30, 2024 | 133.02 | -0.37 |
Primega Group | PGHL | Aug 30, 2024 | 7.90 | 0.00 |
Primerica | PRI | Aug 30, 2024 | 263.23 | +0.63 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.